Keywords: عوامل آنتی ترومبوتیک; Dissection; Mesenteric artery; Antithrombotic agents; Treatment outcome;
مقالات ISI عوامل آنتی ترومبوتیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل آنتی ترومبوتیک; Transcatheter aortic valve implantation; Aortic stenosis; Antithrombotic agents; Thrombosis; Bleeding; TAVI; Rétrécissement aortique; Traitements antithrombotiques; Thrombose; Saignement; AF; atrial fibrillation; DAPT; dual antiplatelet therapy; LVEF; l
Keywords: عوامل آنتی ترومبوتیک; Antithrombotic agents; Gastrointestinal bleeding; Anticoagulants;
Keywords: عوامل آنتی ترومبوتیک; ASDH; acute subdural hematomas; AT; antithrombotic agents; CSDH; chronic subdural hematomas; INR; international normalized ratio; PR; postoperative recurrence; NOS; Newcastle-Ottawa Scale; Anticoagulation; Antiplatelet; Antithrombosis; Chronic subdural he
Keywords: عوامل آنتی ترومبوتیک; Platelet activation; Coagulation; Vascular injury; Arterial thrombosis; Antithrombotic agents; Hemostasis;
Keywords: عوامل آنتی ترومبوتیک; Decision aids; Atrial fibrillation; Antithrombotic agents; Anticoagulants; Validation studies; Patient education
Keywords: عوامل آنتی ترومبوتیک; Endoscopy; Antithrombotic agents; Anticoagulants; Antiplatelet agents;
Keywords: عوامل آنتی ترومبوتیک; Antiphospholipid antibody; Antithrombotic agents; Thrombosis; Prognosis; Recurrence;
Keywords: عوامل آنتی ترومبوتیک; Antithrombotic Agents; Anticoagulants; Poor Clinical Outcomes; Lower Gastrointestinal Hemorrhage; LGIB; Recurrence; Mortality; CI; confidence interval; LGIB; lower gastrointestinal bleeding; NCGM; National Center for Global Health and Medicine; NSAID; non
Antithrombotic activity of Batroxase, a metalloprotease from Bothrops atrox venom, in a model of venous thrombosis
Keywords: عوامل آنتی ترومبوتیک; Batroxase; Snake venom; Metalloproteases; Antithrombotic agents; Venous thrombosis;
Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors
Keywords: عوامل آنتی ترومبوتیک; Coumarins; Factor XIIa; Factor XII; FXII; Antithrombotic agents; Benzopyrans; ADME; absorption, distribution, metabolism and excretion; FXIIa; activated coagulation factor XII; FXa; activated coagulation factor X; THR; thrombin; FVIIa; activated factor VI
Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan
Keywords: عوامل آنتی ترومبوتیک; Antithrombotic agents; Deep vein thrombosis; Total hip arthroplasty; Total knee arthroplasty; Rivaroxaban
Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors
Keywords: عوامل آنتی ترومبوتیک; Thrombosis; FXa inhibitor; 3,4-Diaminobenzoyl-based FXa inhibitors; Antithrombotic agents;
Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation : Insights From the ARISTOTLE Trial
Keywords: عوامل آنتی ترومبوتیک; antiarrhythmia agents; anticoagulants; antithrombotic agents; factor Xa; stroke; thromboembolism; warfarinAF, atrial fibrillation; CHADS2, congestive heart failure, hypertension, age, diabetes, and stroke; CI, confidence interval; HR, hazard ratio; INR, i
A novel antibody targeting the ligand binding domain of the thromboxane A2 receptor exhibits antithrombotic properties in vivo
Keywords: عوامل آنتی ترومبوتیک; Thromboxane A2 receptor; Antibody therapy; Hemostasis; Thrombosis; Antithrombotic agents; Platelets
From snake venom toxins to therapeutics – Cardiovascular examples
Keywords: عوامل آنتی ترومبوتیک; Toxins to therapeutics; Toxins to drugs; Drug discovery; Drug design; Antithrombotic agents; Anti-hypertensive agents; Anti-cancer
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
Keywords: عوامل آنتی ترومبوتیک; AHA Scientific Statements; antithrombotic agents; atrial fibrillation; dabigatran; focused update;
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
Keywords: عوامل آنتی ترومبوتیک; AHA Scientific Statements; Focused update; Atrial fibrillation; Dabigatran; Antithrombotic agents;
Perioperative management of antithrombotic agents in urological surgery
Keywords: عوامل آنتی ترومبوتیک; Urological surgery; Antithrombotic agents; Antiplatelet agents; Anticoagulants; Aspirin; Clopidogrel; Vitamin K antagonists;
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Keywords: عوامل آنتی ترومبوتیک; ACCF/AHA Practice Guidelines; anticoagulant therapy; antiplatelet therapy; antithrombotic agents; atrial fibrillation; catheter ablation; rate control; rhythm control; thromboembolism;
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Keywords: عوامل آنتی ترومبوتیک; AHA Scientific Statements; Atrial fibrillation; Rate control; Rhythm control; Anticoagulant therapy; Antiplatelet therapy; Antithrombotic agents; Thromboembolism; Catheter ablation;
Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa
Keywords: عوامل آنتی ترومبوتیک; Factor Xa inhibitors; Anticoagulants; Antithrombotic agents; Pyrazole; Bicyclic core; Pyrazolo[4,3-d]pyrimidin-7(6H)-ones
Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa
Keywords: عوامل آنتی ترومبوتیک; Factor Xa inhibitors; Anticoagulants; Antithrombotic agents; Pyrazole; Bicyclic core; Pyrazolo[4,3-d]pyrimidin-7(6H)-ones
Estudio descriptivo de las complicaciones vasculares secundarias a antitrombóticos e intervencionismo cardiovascular percutáneo en una unidad coronaria
Keywords: عوامل آنتی ترومبوتیک; Cuidados intensivos enfermerÃa; Infarto agudo de miocardio; Antitrombóticos; Complicaciones vasculares; Angioplastia coronaria; Intensive nursing care; acute myocardial infarction; antithrombotic agents; vascular complications; coronary angioplasty;
Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors
Keywords: عوامل آنتی ترومبوتیک; Serine protease; Factor Xa inhibitors; Antithrombotic agents; 2-Methylbenzofuran; Thiourea; Bioisosteres; N,N′-Disubstituted ketene aminal; 2,2-Dicyanoketene aminal; 2-Nitroketene aminal; Orally active
Risque des antithrombotiques en réanimation
Keywords: عوامل آنتی ترومبوتیک; Anticoagulants; Thrombose; Prévention; Complications hémorragiques; Thrombopénie induite par l'héparine; Réanimation; Antithrombotic agents; Thrombosis; Prevention; Bleeding; Heparin induced thrombocytopenia; Intensive care;
Cardiac surgery in patients on antiplatelet and antithrombotic agents
Keywords: عوامل آنتی ترومبوتیک; cardiac surgery; antithrombotic agents; hemorrhage;
Prescription des héparines de bas poids moléculaire en chirurgie vasculaire : résultats de l'enquête Ephebe
Keywords: عوامل آنتی ترومبوتیک; Chirurgie vasculaire; Traitements antithrombotiques; Héparine de bas poids moléculaire; Vascular surgery; Antithrombotic agents; Low molecular weight heparin;
3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis
Keywords: عوامل آنتی ترومبوتیک; 3D-QSAR; CoMFA; Indole/benzoimidazole-5-carboxamidines; Trypsin-like serine protease inhibitors; Anticancer; Anticoagulants; Antithrombotic agents